NOTCH3 and small cell lung carcinoma: This suggests that either Notch2 or Notch3 inhibition can have therapeutic activity in SCLC cells or that non-cell autonomous effects on tumor stroma mediated by Notch2/3 inhibition are responsible for this effect.